Atlas Trials

Alvotech Swiss AG

20 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Alvotech Swiss AG

RecordFirmDate
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema (NCT07489131)Alvotech Swiss AG2026-04-22
Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio (NCT06732804)Alvotech Swiss AG2025-02-11
Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio (NCT06570772)Alvotech Swiss AG2024-09-23
Pilot Study of AVT16 in Healthy Adult Subjects (NCT06400719)Alvotech Swiss AG2024-05-29
Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease (NCT05986786)Alvotech Swiss AG2024-02-28
AVT03 With Xgeva in Healthy Male Subjects (NCT05876949)Alvotech Swiss AG2023-07-21
Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX (NCT05842213)Alvotech Swiss AG2023-03-30
A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants (NCT05632211)Alvotech Swiss AG2022-12-16
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND (NCT05395091)Alvotech Swiss AG2022-08-23
Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (NCT05155293)Alvotech Swiss AG2022-06-28
Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis (NCT04930042)Alvotech Swiss AG2021-06-03
Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) (NCT04744363)Alvotech Swiss AG2021-05-25
Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis (NCT04453137)Alvotech Swiss AG2020-06-30
Auto-injector Real Life Handling in Patients (NCT04224194)Alvotech Swiss AG2019-11-04
PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI) (NCT03983876)Alvotech Swiss AG2019-07-01
Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab) (NCT03849313)Alvotech Swiss AG2019-03-20
Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis (NCT03849404)Alvotech Swiss AG2019-02-20
Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (NCT03579823)Alvotech Swiss AG2018-05-21

Track Alvotech Swiss AG automatically

Every clearance here is in the API, with alerts when new ones post.